CADENCE PHARMACEUTICALS INC (CADX) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 644 transactions totaling $213.5M, demonstrating a bullish sentiment with $174.5M in net insider flow. The most recent transaction on Mar 19, 2014 involved a transaction of 3,745 shares valued at $52.4K.
No significant insider buying has been recorded for CADX in the recent period.
No significant insider selling has been recorded for CADX in the recent period.
Based on recent SEC filings, insider sentiment for CADX is bullish with an Insider Alignment Score of 91/100 and a net flow of $174.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CADENCE PHARMACEUTICALS INC (CADX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading CADX stock, having executed 644 transactions in the past 90 days. The most active insider is Jesse I. Treu (Executive), who has made 39 transactions totaling $183.1M.
Get notified when executives and directors at CADX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 19, 2014 | M. Aker Hazel | Executive | Tender | 3,745 | $14.00 | $52.4K | |
| Mar 19, 2014 | A. Byrd Scott | Executive | Tender | 2,000 | $14.00 | $28.0K | |
| Mar 19, 2014 | R. Larue William | Executive | Tender | 11,000 | $14.00 | $154.0K | |
| Mar 19, 2014 | R. Larue William | Executive | Tender | 5,000 | $14.00 | $70.0K | |
| Mar 19, 2014 | Lloyd-smith Malcolm | Executive | Tender | 2,332 | $14.00 | $32.6K | |
| Mar 19, 2014 | R. Schroeder Theodore | Executive | Tender | 307,500 | $14.00 | $4.3M | Large |
| Mar 19, 2014 | R. Schroeder Theodore | Executive | Tender | 12,664 | $14.00 | $177.3K | |
| Mar 19, 2014 | G. Atwood Brian | Executive | Tender | 28,787 | $14.00 | $403.0K | |
| Mar 19, 2014 | G. Atwood Brian | Executive | Tender | 1,685,591 | $14.00 | $23.6M | Large |
| Mar 19, 2014 | G. Atwood Brian | Executive | Tender | 10,618 | $14.00 | $148.7K | |
| Mar 19, 2014 | G. Atwood Brian | Executive | Tender | 61,124 | $14.00 | $855.7K | Large |
| Mar 19, 2014 | G. Atwood Brian | Executive | Tender | 3,220,948 | $14.00 | $45.1M | Large |
| Mar 19, 2014 | L. Barker Sam | Executive | Tender | 20,000 | $14.00 | $280.0K | |
| Mar 19, 2014 | D. Frazier Alan | Executive | Tender | 4,796,711 | $14.00 | $67.2M | Large |
| Mar 19, 2014 | D. Frazier Alan | Executive | Tender | 3,816,474 | $14.00 | $53.4M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 34 | $920.3M | 58.9% |
Tender(U) | 20 | $211.1M | 13.5% |
Purchase(P) | 60 | $194.0M | 12.4% |
Award(A) | 42 | $157.4M | 10.1% |
Exercise(M) | 53 | $31.2M | 2.0% |
Payment(F) | 7 | $30.0M | 1.9% |
Sale(S) | 399 | $19.5M | 1.2% |
Other(J) | 3 | $1.3K | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Will Acquisition(W) | 2 | $0 | 0.0% |
Conversion(C) | 21 | $0 | 0.0% |
Insiders at CADENCE PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 34 insiders making 644 transactions totaling $194.0M in purchases versus $19.5M in sales, the net buying activity of $174.5M signals strong executive confidence. Jesse I. Treu (Executive) leads the buying activity with $183.1M in transactions across all time.